Femme et Homme
- | Pays :
- Italy
- United States
- | Organes : -
- | Spécialités : -
Extrait
This is an open-label, dose-escalation study of ARQ 197 administered orally in combination with sorafenib.
Critère d'inclusion
- Advanced solid tumors
This is an open-label, dose-escalation study of ARQ 197 administered orally in combination with sorafenib.